AAVLife's Series A Round

AAVLife raised a round of funding on April 15, 2014.

AAVLife, registered in Paris, is a privately held company dedicated to advancing gene therapy for rare diseases. AAVLife's lead indication is for Friedreich's Ataxia Cardiomyopathy. Its program is bas…

Articles about AAVLife's Series A Round: